Management for Serious Surgical Infection - PowerPoint PPT Presentation

1 / 48
About This Presentation
Title:

Management for Serious Surgical Infection

Description:

Management for Serious Surgical Infection Paul Lai Surgery, CUHK surgeons enemies infection bleeding reconstruction tissue healing lack of patients Outline of the ... – PowerPoint PPT presentation

Number of Views:367
Avg rating:3.0/5.0
Slides: 49
Provided by: MO01
Category:

less

Transcript and Presenter's Notes

Title: Management for Serious Surgical Infection


1
  • Management for Serious Surgical Infection

Paul Lai Surgery, CUHK
2
surgeons enemies
  • infection
  • bleeding
  • reconstruction
  • tissue healing
  • lack of patients

3
Every operation in surgery is an experiment in
bacteriology.
Berkely Moynihan (1920)
4
Outline of the talk
  • Historic perspectives of surgical infection
  • Biology of surgical infection
  • Infection control and prevention
  • Diagnosis and management of serious surgical
    infection
  • Acquired surgical infections

5
Outline of the talk
  • Historic perspectives of surgical infection
  • Biology of surgical infection
  • Infection control and prevention
  • Diagnosis and management of infection
  • Acquired surgical infections

6
History - surgical infection
  • Louis Pasteur
  • Hypothesis of micro-organisms
  • Joseph Lister (18271912)
  • Carbonic acid spray
  • Anti-sepsis and asepsis
  • William Halsted (18521922)
  • Promote hand washing and gloves
  • Alexander Fleming (18811955)
  • Discovery of penicillin

7
Outline of the talk
  • Historic perspectives of surgical infection
  • Biology of surgical infection
  • Infection control and prevention
  • Diagnosis and management of infection
  • Acquired surgical infections
  • Case presentation

8
(No Transcript)
9
Risk of wound infection
Type Definition Example Infection risk ()
Clean No breech of GIT Hernia repair 2
Clean-contaminated Prepared GIT Elective colectomy 5
Contaminated Unprepared bowel opened Emergency colectomy 15
Dirty Pus at operative site / perforated bowel Perforated appendicitis 40
10
Outline of the talk
  • Historic perspectives of surgical infection
  • Biology of surgical infection
  • Infection control and prevention
  • Diagnosis and management of infection
  • Acquired surgical infections
  • Case presentation

11
Surgical Site Infections
  • Despite extensive use of disinfectants,
    anti-septics and sterilization procedures in
    patients and instruments, SSI remains the second
    most common cause of nosocomial infection
  • Patients who develop SSI are up to 60 more
    likely to spend time in the ICU, 5 times more
    likely to be readmitted, 2 times more likely to
    die than are patients without an SSI

12
General recommendation from National Surgical
Infection Prevention Project of CDC
  • Antimicrobial prophylaxis
  • identify high risk patients and procedures
  • timing and duration
  • choice of antibiotics
  • intra-operative dosing

CID 200438 1706-1715
13
General recommendation from National Surgical
Infection Prevention Project of CDC
  • 1) Antimicrobial prophylaxis
  • Achieve serum and tissue drug levels that exceed
    the MICs (Minimal Inhibitory Concentrations) for
    the organisms likely to be encountered during the
    operation
  • Initiated within 60 min of incision on
    induction
  • For Fluoroquinolones and vancomycin infusions
    begin within 120 min before incision, because it
    would take 60 min for slow infusion

CID 200438 1706-1715
14
General recommendation from National Surgical
Infection Prevention Project of CDC
  • 2) Duration
  • Majority of published evidence demonstrates that
    antimicrobial prophylaxis after wound closure is
    unnecessary, no additional benefits
  • Prolonged use asso. with emergence of resistant
    strains
  • End within 24 hour after the operation
  • Single exception cardiothoracic surgery, up to
    72 hours

CID 200438 1706-1715
15
General recommendation from National Surgical
Infection Prevention Project of CDC
  • 3) Choice of antibiotics
  • Clean target against Gram positive organism
    cefazolin or cefuroxime
  • Cut across mucosa eg GI surgery Gram positive,
    Gram negative and anaerobes cefuroxime plus
    metronidazole
  • B lactam allergy alternative clindamycin or
    vancomycin
  • Known MRSA colonization vancomycin as
    prophylaixs
  • Mupirocin application - can eradicate nasal
    colonization of Staph aureus but do not
    demonstrate reduction of SSI rates

CID 200438 1706-1715
16
General recommendation from National Surgical
Infection Prevention Project of CDC
  • 4) Intra-operative dosing
  • Indicated when the duration of surgery exceed 2
    times of the half life of the antibiotics

Anitibiotics Half life (hr) Redosing interval (hr)
Cefuroxime 1-2 3-4
Metronidazole 6-14 6-8
Gentamicin 2-3 3-6
17
Other recommendations from CDC
  • Anaesthesia
  • maintain normothermia intra-operatively
  • peri-operative optimisation of oxygen tension
  • maintain glucose control in DM patients
  • Patient and OT
  • stop smoking prior to surgery
  • avoid shaving, use clips for hair removal
  • pre-op shower with anti-septic soap
  • sterile operating room from filtered air to
    instruments

18
Some minor things that surgeons can do
X
  • wear a mask
  • wear sterile gloves
  • keep the nails short
  • scrub properly
  • talk less during surgery
  • reduce bleeding
  • gentle tissue handling
  • delayed primary closure for heavily contaminated
    wounds
  • exclude infected surgeons

19
Surgical Site Infections Surveillance
  • Criteria according to NNIS ( National Nosocomial
    Infection Surveillance )
  • Including Post Discharge Surveillance
  • 30 days after the operation
  • Quarterly and yearly report
  • Overall infection rates
  • Distribution by team
  • Surgeon specific rates (coding) with infected
    patient list attached (for verification if
    required)
  • Distribution by surgery types

20
SSI rates compared to reference
39.9
26.3
21.3
15.4
14.6
13.3
11.3
8.7
9.1
6.3
7.5
1.4
21
(No Transcript)
22
Outline of the talk
  • Historic perspectives of surgical infection
  • Biology of surgical infection
  • Infection control and prevention
  • Diagnosis and management of infection
  • Acquired surgical infections
  • Case presentation

23
Diagnosis and management of surgical infection
  • history and physical examination
  • timing of post-operative infection
  • blood tests
  • microbiological analysis
  • radiological imaging
  • resuscitation
  • fluid and electrolytes
  • analgesia
  • anti-emetics
  • empirical antibiotics treatment

24
post-operative peritonitis
negative abdominal CT
positive abdominal CT
if other infections found
rule out other infections
accessible by percutaneous method
not accessible by percutaneous method OR severe se
psis
percutaneous aspiration or drainage
treat accordingly
consider abdominal re-exploration
25
Surgical principles on exploration
  • do drain the drainable and leave drainage tubes
    behind (concept of controlled fistulation)
  • do debride the obviously dead or ischaemic
    tissues
  • do create stomas if anastomosis is risky
  • do bear in mind the concept of damage control
    surgery
  • do plan re-exploration if necessary
  • dont sit too tight on conservative or
    interventional radiological treatments
  • dont get into the theatre too late

26
Liver abscess
27
Liver Abscess
28
Gross specimen of a liver abscess
29
Severe necrotizing pancreatitis
30
Severe necrotizing pancreatitis
31
From the previous patient
32
Sepsis leading to SIRS MODS
  • GI tract as a reservoir of bacteria
  • Bacterial translocation as a result of mucosal
    barrier breaking down
  • Translocation is promoted by hypovolaemic shock,
    intestinal obstruction and malnutrition
  • Bacteria and endotoxin can then trigger release
    of pro-inflammatory cytokines locally and
    systemically
  • Left untreated, systemic inflammatory response
    syndrome (SIRS) and multi-organ dysfunction
    syndrome (MODS) would set in

33
Management strategies in patients with severe
sepsis
  • Stop bacterial spillage into systemic circulation
  • correct surgical pathologies
  • correct factors that would enhance bacterial
    translocation
  • selective use of antibiotics (-)
  • enteral nutrition (?) to keep the gut barrier
    intact
  • probiotics, glutamine or anti-oxidants,
    dopexamine
  • Organ support
  • aggressive monitoring of cardiac output, blood
    flow and tissue oxygenation
  • get the fluid, inotropes and ventilatory support
    right
  • concept of goal-directed therapy

34
Outline of the talk
  • Historic perspectives of surgical infection
  • Biology of surgical infection
  • Infection control and prevention
  • Diagnosis and management of infection
  • Acquired surgical infections
  • Case presentation

35
Acquired surgical infections
  • The operative sites
  • Wounds
  • Cavities
  • In relation to a prosthesis
  • Respiratory tract
  • Gastrointestinal tract
  • pseudomembranous colitis
  • Urinary tract
  • Intravenous lines
  • Cross infections

36
MRSA
37
Methicillin-resistant staphylococcus aureus
(MRSA)
  • It is a by-product of modern and advanced medical
    care
  • Rapid rise in incidence all over the world since
    1990
  • Serious financial implications for the treatment
    of MRSA infection
  • MRSA is around us silently and being
    opportunistic

38
Rates of MRSA in ICU during SARS
Yap FH et al., Clin Infect Dis 2004 39511-516.
39
Which organ did the MRSA affected?
Yap FH et al., Clin Infect Dis 2004 39511-516.
40
Ventilator-associated pneumonia (VAP)
  • Higher incidence of bacteraemia, septic shock and
    mortality in MRSA infection
  • Vancomycin therapy for MRSA is not very
    satisfactory
  • Linezolid (Zyvox) has superior tissue penetration
    compared with glycopeptides
  • Linezolid initial therapy for MRSA HAP/VAP is
    associated with significantly better survival and
    clinical cure
  • Linezolid was an independent predictor of
    survival in MRSA VAP

  • Kollef MH e al., 2004 30388-394.

41
(No Transcript)
42
Significant predictors of clinical cureVAP
patients (n434)
OR 1.6, p0.048
Mech vent lt7days
OR 5.6, p0.02
Cr lt2.6 mg/dl
OR 2.0, p0.001
Age lt65y
OR 1.6, p0.04
Single lobe
OR 2.8, plt0.001
APACHE II score
OR 1.8, p0.008
Linezolid therapy
0
1
2
3
4
5
6
Kollef M, et al. Intensive Care Med 2004 30
388-94
43
Surgical site MRSA infection
  • Linezolid (Zyvox) is better for surgical site
    MRSA infection
  • 98 vs. 48 microbiologically cured P0.0022
  • Weigelt J et al., Am
    J Surg 2004 188760-766
  • Issues to consider
  • Myelosuppression (thrombocytopenia more commonly
    seen in patients treated for gt2 weeks)
  • Cost of treatment
  • relatively little data on the use of Linezolid in
    intra-abdominal sepsis

44
Percentage of MRSA in staphylococcus aureus
bacteraemia
45
(No Transcript)
46
What did we do about it?
  • (1) Audit
  • Hand hygiene after removal of gloves
  • Hand hygiene after contact with patient's intact
    skin, i.e. physical exam, lifting
  • Wash hands before after invasive procedures
    e.g. injection, I.V. insertion, blood taking,
    care of long line, suction
  • Wash hands after handling contaminated
    items/site e.g. bedpans, urine bag, incontinence
    pad, wastes, wound dressing

47
(No Transcript)
48
(No Transcript)
49
What did we do about it?
  • (2) Hand washing campaign

50
(No Transcript)
51
alcohol-based handrubs are more efficient
52
NTEC Hand Hygiene Audit Overall Compliance
() Compliance Rate
53
New MRSA isolates per 1000 DD
54
(No Transcript)
55
ESBL-producing bacteria
  • ESBL stands for extended spectrum
    beta-lactamase
  • Not a single enzymes but gt170 ESBLs
  • Most commonly found in E.Coli and Klebsiella
    pneumonia
  • People with weaker immunity are at risk
  • Can spread through contacts (e.g. healthcare
    workers)

56
ESBL-producing bacteria - issues
  • Difficult to detect need more intensive
    screening and susceptibility tests
  • Its prevalence is probably underestimated
  • High risk groups
  • Emergency intra-abdominal surgery
  • ICU stay with all sorts of lines and tubes
  • Prior antibiotics treatments
  • Treatment is difficult
  • Total resistance
  • Clinical reduction in efficacy on standard dose

57
Infection control - ESBL
  • Antibiotic selection pressure
  • Plasmid carrying ESBL genes can be disseminated
    through species
  • Restrict use of antibiotics especially
    cephalosporins
  • Contact precautions (gloves and gowns)

58
(No Transcript)
59
Thank You
www.surgery.cuhk.edu.hk
Write a Comment
User Comments (0)
About PowerShow.com